Actual Medicinal Product (AMP) Bicalutamide 150mg tablets (Accord-UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Manufacturer recommends storing in original container
- Provenance
-
This recommendation is based on the products Casodex 150mg film coated tablets (AstraZeneca UK Limited) and Bicalutamide 150mg film coated tablets (Morningside Healthcare Ltd).
- Generic
- Bicalutamide
- Formulation
- Bicalutamide 150mg tablets
-
Bicalutamide
-
Bicalutamide 150mg tablets
-
Bicalutamide 150mg tablets (Accord-UK Ltd)
-
-